Smoking Status and Tobacco-Associated Cancer Site Profiles: A Multivariable Case-Case Analysis of Oncology Registry Records in Iraq Case-Case Analysis of Oncology Registry
01Abstract
Background: Tobacco smoking has been associated with a number of malignancies including the lung, larynx and urinary bladder. However, the smoking status patterns reported by Iraqi oncology registries are not properly characterized at the site-specific level. Hospital-based case–case analyzes may not be able to establish population-level cancer risks but they may offer useful insights into these patterns. Objective: To investigate the associations between relative representation of lung, laryngeal and urinary bladder cancers in the records of oncology registry in Iraq, after controlling for age, sex and registration year, and documented current and former smoking. Methods: We conducted a retrospective registry-based case-control study using five annual oncology datasets from 2022 to 2026. To be eligible, the records must have included a diagnosis of a recognizable malignant neoplasm (ICD-10 C00–C97), an interpretable age and sex, and a documented smoking status. Smoking was classified as current, former, or documented nonsmoking. Lung (C34), laryngeal (C32) and urinary bladder (C67) cancers were compared with other registered malignancies in separate multivariable logistic regression models, adjusted for age, sex and registration year. Six major smoking-cancer associations were evaluated. Benjamini–Hochberg procedure was selected for multiple testing correction. Sensitivity analyzes excluded records from 2026 and secondary analyzes estimated current or former smoking combined. Results: The reported analytical cohort included 11,664 eligible registry records, of which 2,092 (17.9%) current smokers, 1,518 (13.0%) former smokers, and 8,054 (69.1%) recorded nonsmokers. Current or previous smoking was recorded in 74.4% of lung cancer, 82.8% of laryngeal cancer and 66.5% of urinary bladder cancer records. Current smokers had higher adjusted odds of lung cancer (aOR 6.72; 95% CI 5.64-8.01), laryngeal cancer (aOR 9.81; 95% CI 6.13-15.71) and urinary bladder cancer (aOR 2.71; 95% CI 2.18-3.36) than recorded nonsmokers. Corresponding estimates for ex-smokers were 4.68 (95% CI 3.87-5.67), 9.06 (95% CI 5.47-14.99), and 2.12 (95% CI 1.67-2.69). The source analysis, corrected for multiple-testing, demonstrated statistically significant associations. Positive associations for lung and laryngeal cancers were retained in restricted-period analyzes, but a stable restricted-period bladder cancer estimate was not available. Conclusions: The relative percentages of lung, laryngeal and urinary bladder cancer diagnoses in this institutional oncology registry were associated with documented current and former smoking. These results are consistent with what is already known about tobacco-related cancers, but they should be interpreted as associations in individual cases, rather than as estimates of the risk of cancer in the population. Better documentation of smoking, identification of patients and validation of registry data is essential to reinforce future oncology research in Iraq.
02Authors
03Article Details
- Section
- Articles Publishing terms and rules
- Pages
- 136-166
- Published
- 2026-10-31
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
04References
- 1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263. DOI: 10.3322/caac.21834
- 2. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 83. Lyon: IARC; 2004.
- 3. U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta: Centers for Disease Control and Prevention; 2014.
- 4. 4.International Agency for Research on Cancer. Reversal of risk after quitting smoking. IARC Handbooks of Cancer Prevention. Vol. 11. Lyon: IARC; 2007.
- 5. Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155–164. DOI: 10.1002/ijc.23033
- 6. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296. DOI: 10.1371/journal.pmed.0040296
- 7. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. DOI: 10.1371/journal.pmed.1001885
- 8. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B. 1995;57(1):289–300.
- 9. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409–2419. DOI: 10.1002/sim.1047
- 10. Jubber I, Ong S, Bukavina L, Black PC, Compérat E, Kamat AM, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176–190. DOI: 10.1016/j.eururo.2023.03.029
- 11. Zuo JJ, Tao ZZ, Chen C, Hu ZW, Xu YX, Zheng AY, et al. Characteristics of cigarette smoking without alcohol consumption and laryngeal cancer: overall and time-risk relation. A meta-analysis of observational studies. Eur Arch Otorhinolaryngol. 2017;274(3):1617–1631. DOI: 10.1007/s00405-016-4390-x
- 12. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. 2001;31(2–3):139–148. DOI: 10.1016/S0169-5002(00)00181-1
- 13. Puente D, Hartge P, Greiser E, Cantor KP, King WD, Gonzalez CA, et al. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Causes Control. 2006;17(1):71–79. DOI: 10.1007/s10552-005-0389-0
- 14. Ibrahim BA, Al-Humadi AH, Al-Humadi HW. Tobacco smoking, lung cancer, and therapy in Iraq: current perspective. Front Public Health. 2018;6:311. DOI: 10.3389/fpubh.2018.00311
- 15. Kudhair BK, Abdulridha FM, Hussain GM, Lafta IJ, Alabid NN. The association of combined GSTM1, GSTT1, and GSTP1 genetic polymorphisms with lung cancer risk in male Iraqi waterpipe tobacco (Nargila) smokers. Cancer Epidemiol. 2024;93:102689. DOI: 10.1016/j.canep.2024.102689
- 16. Waziry R, Jawad M, Ballout RA, Al Akel M, Akl EA. The effects of waterpipe tobacco smoking on health outcomes: an updated systematic review and meta-analysis. Int J Epidemiol. 2017;46(1):32–43. DOI: 10.1093/ije/dyw021
- 17. Abd Al-Badri HJ, Ali RM, Al-Doori HH, Al-Musawi MA, Al-Saadi AH, Al-Rubaie HA. Socio-economic determinants of smoking among Iraqi adults: data from Non-Communicable Risk Factor STEPS survey 2015. PLoS One. 2017;12(9):e0184989. DOI: 10.1371/journal.pone.0184989
- 18. Hussain AM, Lafta RK, Al-Shatari SA, Al-Dulaimi AK, Al-Rawi RA. Cancer trends in Iraq 2000–2016. Oman Med J. 2021;36(1):e219. DOI: 10.5001/omj.2021.18
- 19. Li Y, Zhang X, Wang Y, Chen J, Liu H, Zhao Q, et al. Global burden and cross-national inequalities of tobacco-attributable cancers in adults aged 40 and above, 1990–2021: a population-based study. Front Oncol. 2025;15:1631356. DOI: 10.3389/fonc.2025.1631356
- 20. Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024;93:102693. DOI: 10.1016/j.canep.2024.102693
- 21. Rachet B, Siemiatycki J, Abrahamowicz M, Leffondré K. A flexible modeling approach to estimating the component effects of smoking behavior on lung cancer. J Clin Epidemiol. 2004;57(10):1076–1085. DOI: 10.1016/j.jclinepi.2004.02.014
- 22. Choi SY, Kahyo H. Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol. 1991;20(4):878–885. DOI: 10.1093/ije/20.4.878
- 23. Vaezi MF, Qadeer MA, Lopez R, Colabianchi N. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med. 2006;119(9):768–776. DOI: 10.1016/j.amjmed.2006.01.019
- 24. Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, et al. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev. 2000;9(5):461–467.
- 25. Samet JM. The health benefits of smoking cessation. Med Clin North Am. 1992;76(2):399–414. DOI: 10.1016/S0025-7125(16)30365-0
- 26. Li L, Cao Y, Zhang W, Chen X, Wang H, Liu Y, et al. Survival among US adults with post-cancer-diagnosis cigarette smoking cessation. Cancer Causes Control. 2026. Epub ahead of print. DOI: 10.1007/s10552-026-02345-8
- 27. Zi M, Zhang Y, Wang X, Li J, Chen L, Zhao H, et al. Global burden of smoking-attributable digestive cancers from 1990 to 2021: insights from the Global Burden of Disease study. Int J Surg. 2025. Epub ahead of print. DOI: 10.1097/JS9.0000000000003408
- 28. Wan W, Zhang Y, Liu X, Chen Z, Wang L, Li H, et al. Occupational benzene exposure and lung cancer in human studies: a systematic review and meta-analysis. Environ Health Perspect. 2024;132(12):126001. DOI: 10.1289/EHP15086
- 29. Hassan FM. Risk factors associated with breast cancer among women in Iraq: a case-control study. Asian Pac J Cancer Prev. 2025;26(5):1701–1708. DOI: 10.31557/APJCP.2025.26.5.1701
- 30. Al-Fouadi A, Parkin DM. Cancer in Iraq: seven years' data from the Baghdad Tumour Registry. Int J Cancer. 1984;34(2):207–213. DOI: 10.1002/ijc.2910340211
- 31. Al Adnani MS, Saleh KM. Schistosomiasis and bladder carcinoma in southern Iraq. J Trop Med Hyg. 1983;86(3):115–119.
- 32. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. DOI: 10.3322/caac.21492
- 33. Mamtani R, Cheema S, Sheikh J, Al Mulla A, Lowenfels AB, Maisonneuve P. Cancer risk in waterpipe smokers: a meta-analysis. Int J Public Health. 2017;62(1):73–83. DOI: 10.1007/s00038-016-0856-2
- 34. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA. 2011;306(7):737–745. DOI: 10.1001/jama.2011.1142
